← back to search

Christophe von Garnier

University of Bern · CH
Area of research
Pulmonary and Respiratory Medicine · Physiology
Research interest
Research interests include Chronic Obstructive Pulmonary Disease (COPD) Research, Asthma and respiratory diseases, Inhalation and Respiratory Drug Delivery, and Immunotherapy and Immune Responses.
h-index
39
citations
6,402
works
342
NIH funding
primary concept
Medicine
email

Recent publications

Prevalence and Environmental Correlates of Small Airways Dysfunction in a Rural Swiss Cohort.
2026cited by 1position: contributordoi
Approaches for Lung Fiducial Markers Insertion in Stereotactic Body Radiotherapy: A Systematic Review and Meta-Analysis.
2026cited by 0position: contributordoi
Impact of Transitioning from Race-Specific to Race-Neutral GLI Equation on Lung Function in a Predominantly Caucasian Population.
2026cited by 0position: contributordoi
Eligibility for Lung Cancer Screening in Switzerland: A Comparative Analysis of Three Data Sources From Lausanne and the Canton of Vaud.
2026cited by 0position: contributordoi
The needs and expectations of people eligible for lung cancer screening in Switzerland: A mixed method study.
2026cited by 0position: contributordoi
Association Between Exertional Dyspnea and OSA.
2026cited by 0position: contributordoi
Respiratory and Gut Microbiota Correlate with Lung Function Recovery after Severe COVID-19
2026cited by 0position: contributordoi
Poor discriminative abilities of age, duration and pack-years smoking exposure for diagnosing small airways dysfunction
Respiratory Medicine and Research 2026cited by 0position: contributordoi
Heme-induced lung injury in human precision cut lung slices: a new model for acute lung injury.
2025cited by 2position: contributordoi
Harnessing deep learning to detect bronchiolitis obliterans syndrome from chest CT
Communications Medicine 2025cited by 2position: contributordoi
Modulation of allergic airways disease employing bio-mimetic nanoparticles with TLR agonists.
2025cited by 1position: contributordoi
Post-viral lung diseases: the microbiota as a key player.
2025cited by 1position: contributordoi
The Effect of Comorbidities on Asthma-Related Outcomes Over a Two-Year Period: A Prospective Analysis of Swiss Severe Asthma Registry (SSAR).
2025cited by 1position: contributordoi
[Vaccination for chronic lung disease].
2025cited by 0position: contributordoi
Générer ou guider ? Penser la recherche médicale face à l’IA générative.
2025cited by 0position: contributordoi
Chimeric Allergen Receptor regulatory T cells suppress birch pollen allergic airway inflammation.
2025cited by 0position: contributordoi
A statistical model for tuberculosis diagnosis to guide multi-test strategies and clinical decision-making
2025cited by 0position: contributordoi
Association between small airway dysfunction and cardiac conditions: a Swiss urban population cross-sectional study.
2025cited by 0position: contributordoi
Clinical Remission in Severe Asthma: A Comparative Analysis of Patients with and Without Biologics from the Swiss Severe Asthma Registry.
2025cited by 0position: contributordoi
Association between BRINDA-corrected iron metabolism and lung function in the community: the CoLaus|PneumoLaus study.
2025cited by 0position: contributordoi
Fighting <i>Aspergillus</i> infection using biocontrol bacteria: A proof-of-concept of environmental interference in a translational setting
2025cited by 0position: contributordoi
Proteomic and Transcriptomic Signatures of Poor Asthma Symptom Control in the U-BIOPRED Cohort.
2025cited by 0position: contributordoi
Physical activity and lung function association in a healthy community-dwelling European population.
2024cited by 6position: contributordoi
Vaccination in adult patients with chronic lung diseases.
2024cited by 4position: contributordoi
Associations of Depressive and Anxiety Disorders with Pulmonary Disorders in the Community: The PneumoLaus and PsyCoLaus Studies.
2024cited by 3position: contributordoi
Use of a novel microbiome modulator improves anticancer immunity in a murine model of malignant pleural mesothelioma.
2024cited by 2position: contributordoi
Targeting Immune Cells.
2024cited by 1position: contributordoi
One-Step Soft Agar Enrichment and Isolation of Human Lung Bacteria Inhibiting the Germination of <i>Aspergillus fumigatus</i> Conidia.
2024cited by 1position: contributordoi
Créer l’avenir….
2024cited by 0position: contributordoi
What makes asthma characterized by airway eosinophilia become severe?
2024cited by 0position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 11 papers (2020–2026)Thomas Geiser · University of Bern10 papers (2019–2023)Martin H. Brutsche · Sorbonne Université5 papers (2021–2023)Angela Koutsokera · University Hospital of Lausanne5 papers (2020–2025)John-David Aubert · BMJ Publishing Group4 papers (2020–2025)Niki Ubags · University of Lausanne4 papers (2023–2026)Peter Vollenweider · Atlanta VA Medical Center4 papers (2023–2026)Eric Bernasconi · Lausanne University Hospital and University of Lausanne4 papers (2020–2026)Alessio Casutt · University Hospital of Lausanne4 papers (2023–2026)Brice Touilloux · University of Fribourg4 papers (2023–2026)Aurélien Trompette · University of Lausanne3 papers (2024–2026)Ratko Djukanovic · University Hospital Southampton NHS Foundation Trust3 papers (2019–2025)Pedro Marques-Vidal · University of Lausanne3 papers (2023–2025)Anne Bergeron · Institut universitaire de cardiologie et de pneumologie de Québec3 papers (2022–2024)Martin Preisig · Center for Research in Psychopathology and Clinical Psychology2 papers (2023–2024)Marek Sanak · APC Microbiome Institute2 papers (2019–2019)Michele De Palma · SIB Swiss Institute of Bioinformatics2 papers (2024–2025)Marco Pagni · Laboratoire National de Référence2 papers (2024–2025)Minh Khoa Truong · University of Lausanne2 papers (2023–2025)Sudip Das · Utkal University2 papers (2020–2021)